Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises’ R&D investment: a difference-in-differences analysis in China

ObjectiveThis study aimed to evaluate the impact of the National Centralized Drug Procurement (NCDP) policy on chemical pharmaceutical enterprises’ R&D investment and provide references for improving NCDP policy design and encouraging innovation in the pharmaceutical industry.MethodsUsing th...

Full description

Bibliographic Details

Published in:	Frontiers in Public Health
Main Authors:	Jiaming Li, Xinyue Zhang, Rui Wang, Keyao Cao, Luhui Wan, Xu Ren, Jinxi Ding, Wei Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-07-01
Subjects:	National Centralized Drug Procurement policy chemical pharmaceutical enterprise R&D investment influence mechanism difference-in-difference analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2024.1402581/full